Please assess the completion status of the following clinical trial:

Trial Title: Rasagiline Tablets Special Drug Use-Results Survey Survey on Long-term Safety

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~-Patients with Parkinson's disease should be surveyed.~Exclusion Criteria:~-Participants who have contraindications on package insert of rasagiline.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rasagiline 1 mg (Type: None): Rasagiline 1 milligram (mg), orally, once daily for up to 24 months. Participants received interventions as part of routine medical care.

Based on this trial design, predict the completion outcome and termination type (if applicable).